{"title": "Discovery may lead to precision-based strategy for triple negative breast cancer", "title_detail": {"type": "text/plain", "language": null, "base": "https://www.sciencedaily.com/rss/matter_energy/biochemistry.xml", "value": "Discovery may lead to precision-based strategy for triple negative breast cancer"}, "links": [{"rel": "alternate", "type": "text/html", "href": "https://www.sciencedaily.com/releases/2019/03/190321130449.htm"}], "link": "https://www.sciencedaily.com/releases/2019/03/190321130449.htm", "summary": "A researcher in the Vera Bradley Foundation Center for Breast Cancer Research at the Indiana University School of Medicine, working in collaboration with researchers from the University of Maryland, recently reported several important findings related to triple negative breast cancer and its future treatment in the journal Nature Nanotechnology.", "summary_detail": {"type": "text/html", "language": null, "base": "https://www.sciencedaily.com/rss/matter_energy/biochemistry.xml", "value": "A researcher in the Vera Bradley Foundation Center for Breast Cancer Research at the Indiana University School of Medicine, working in collaboration with researchers from the University of Maryland, recently reported several important findings related to triple negative breast cancer and its future treatment in the journal Nature Nanotechnology."}, "published": "Thu, 21 Mar 2019 13:04:49 EDT", "published_parsed": [2019, 3, 21, 17, 4, 49, 3, 80, 0], "id": "https://www.sciencedaily.com/releases/2019/03/190321130449.htm", "guidislink": false}